MAYNE PHARMA GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.93 AUD | -2.39% |
|
+4.05% | +12.68% |
| 02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
| 02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Evolution of the average Target Price on Mayne Pharma Group Limited
Price target over the last 5 years
History of analyst recommendation changes
97c7be34de5c62a3cea0bc82edb4.2xR4Z_O8xPkn8HbMKKeYFw_r1C_m8qvwBvMrWNeq-SM.lDkcFcfM8bJLqU-qGdXBQUK55BfftOefQ4IZPqHsmFGYVxkew8qDlFTGGQ~77bea3f8de663fe6fb311eedc75c8a10
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.93
AUD
Average target price
7.035
AUD
Spread / Average Target
+1.52%
High Price Target
7.38
AUD
Spread / Highest target
+6.49%
Low Price Target
6.69
AUD
Spread / Lowest Target
-3.46%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
- Stock Market
- Equities
- MYX Stock
- Consensus Mayne Pharma Group Limited
